News & Media
Tuesday, May 5, 2020
Sunnybrook researchers awarded $1.84 million for further study of synthetic cannabinoid in Alzheimer’s disease
Sunnybrook researchers awarded $1.84 million for further study of synthetic cannabinoid in Alzheimer’s disease
Tuesday, April 28, 2020Can an existing HIV medication slow the spread of COVID-19? Team of Toronto researchers launches clinical trial to find out
Thursday, April 23, 2020Can intravenous vitamin C help critically ill COVID-19 patients? Sunnybrook's LOVIT trial aims to find out
Wednesday, April 15, 2020
Participate in COVID-19 research at Sunnybrook
Participate in COVID-19 research at Sunnybrook
Thursday, April 9, 2020
Canadian hospitals trialing new treatment options for COVID-19 patients
Canadian hospitals trialing new treatment options for COVID-19 patients